on the wrong side of where she needs to be
for all the breathing
Her arms look like all the arms lucky you so no eyes stare
Liar liar arms on fire
Her presence is a knocking is a nuisance
but the doors stay closed.
JANE AND THE HOLY TRINITY (AND THE SPHENOPALATINE GANGLION BLOCK)
When the doctor slides the shush
Young Lady Jane's lips want something red.
Doesn’t matter where that tree might be.
THE SHAPE OF JANE
When fully folded,
Girl’s got three disulfide bridges
She is her own ring structure.
Girl’s got chemical, thermal,
Look closely. Girl’s the shape of venom.
Her peptide backbone is pierced. Look out!
JANE'S COMFORT WORDS
α-adrenergic antagonist, aberrant expression noncoding RNAs, acetylcholine, afferent neurons, aggregate data, allodynia, amygdala, anesthetic ketamine, ANOVA, antiallodynic effects, aryl hydrocarbon receptor signaling, biomarkers, bisphosphonates, bulbospinal inhibition, calcitonin, cAMP-mediated signaling, chemokine signaling, coagulation system, conopeptide, Conus magus, clinically relevant, coefficient of determination, complete remission, complex hierarchical interaction, confidence interval, confidence limit, deep brain stimulation, diagnostic criteria, distinct transcriptional changes, dorsal horn, dorsomedial prefrontal cortex, double-blind trial, efferent neurons, efficacy, electron microscopic analyses, epidemiology, etiology, evidence-based intervention, fluoroscopy, fMRI, functional restoration, gabapentin, gene-related peptide, genome-wide expression profiling, glial cells, glucocorticoids, glycogen degradation, granzyme A signaling, hemispherical asymmetry, hippocampus, hydrophilic molecule, hyperalgesia, immunohistochemical techniques, immunomodulatory effects, increased echogenicity, increased gray matter density, infrared telethermography, intercellular cascade, interexaminer reliability, interleukin1 receptor antagonist, intractable, intraepidermal nerve fibers, intrathecal infusion, in vitro, in vivo, ischemia-reperfusion injury, Jane, Jazz Pharmaceuticals, joint stability, keratinocyte proliferation, L-arginine, L-aspartate, L-glutamate, L-kynurenine, L-ornithine, L-tryptophan, linear kinetics, lower extremity, lumbar sympathetic block, McGill Pain Questionnaire, microvascular endothelial cells, midazolam, mirror therapy, morphological macrovascular alterations, molecular insights, monocyte chemotactic protein-1, motor cortex, musculoskeletal ultrasonography, myoclonus, N-methyl-D-aspartate receptor, N-methyl-D-aspartate receptor antagonist, N-type voltage-dependent calcium channel, Naltrexone, NK1 receptor antagonist LY303870, NK1 receptor up-regulation, non-opioid analgesic, norepinephrine reuptake inhibitor, Not-Jane, neuro-cutaneous inflammatory signaling, neural switch, neuroimaging, neuromodulation, neuropeptide mediators, neuroplasticity, neurorehabilitation, novel pharmaceutical class, novel therapeutic targets, nuclear factor-kappa beta, Nucynta, null hypothesis, oxidative stress, outcome measure, outcome prediction, p-value, pain-related genes, paraforaminal stimulation, parasympathetic nervous system, pathogenesis, pathological sympatho-afferent coupling, pathophysiology, perpetuating biopsychosocial factors, placebo-controlled, plasma levels, peripheral and central factors, peripheral blood mononuclear cells, phenoxybenzamine, precipitate, previously refractory, primary afferent nociceptors, prism adaptation paradigm, PRIZM, promising treatment, QSART responses, quantitative sudomotor axon response testing, quantitative three-phase bone scintigraphy, randomized controlled studies, reduction of bone demineralization, reliability, reorganization of thalamo-cortical somatosensory maps, reversible serious adverse events, sensory afferent axons, small-fiber distal nerves, somatosensory cortex, sphenopalatine ganglion block, spinal cord stimulation, spinal interneurons, spinocerebral tract, spinothalamic tract neurons, statistically significant, stellate ganglion block, subanesthetic ketamine, substance P, supraspinal mechanisms, sympathetically maintained pain, sympathetic neurotransmitters, sympathetic nervous system, synapse, systemic markers, thalamic transmission, therapeutic window, thulium yttrium–aluminum granate infrared laser, titration schedule, treatment modalities, two-sample t-test, ultrasound therapy, underlying pathophysiological mechanisms, upper extremity, validated and standardized guidelines, vasoconstriction, vestibular, Visual Analogue Scale, voxel-by-voxel statistics, warm phase, wind down, wind up, Wong-Baker FACES Pain Rating Scale, x-axis, x-ray validation, xerosis, y-axis, yttrium-90 silicate radionuclide synovectomy, z-score, ziconotide, Zoloft, ω-conotoxin MVIIA